JSM 2004 - Toronto

JSM Activity #220

This is the preliminary program for the 2004 Joint Statistical Meetings in Toronto, Canada. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 7-10, 2004); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

Back to main JSM 2004 Program page
Legend: = Applied Session, = Theme Session, = Presenter
FRY = Fairmont Royal York, ICH = InterContinental Hotel, TCC = Metro Toronto Convention Center
Add To My Program
220 Tue, 8/10/04, 10:30 AM - 12:20 PM TCC-718 B
Interim Analysis and Two Step Designs - Contributed - Papers
Biopharmaceutical Section
Chair(s): Neal Thomas, Pfizer Inc.
     10:35 AM   Adjusting Significant Level for Interim Analysis Using Resampling Technique — Yi-wen Ma, Johnson & Johnson Pharmaceutical R&D, LLC; Akiko Okamoto, Johnson & Johnson Pharmaceutical R&D, LLC; Surya Mohanty, Johnson & Johnson Pharmaceutical R&D, LLC
     10:50 AM   Sequential Methods with Recurrent Events — Michael Shnaidman, Columbia University; Zhiliang Ying, Columbia University
     11:05 AM   A Method to Estimate the Variance of an Endpoint from an Ongoing Blinded Trial — Jitendra Ganju, Chiron Corporation; Biao Xing, University of California, Berkeley
     11:20 AM   Application of Statistical-Decision Theory to Strategic Trial Design — A. Lawrence Gould, Merck & Co., Inc.; Julie G. Ma, Merck & Co., Inc.; Michael Nessly, Merck & Co., Inc.
     11:35 AM   Internal Pilot Designs with Compound Symmetric and Gaussian Repeated Measures — Christopher S. Coffey, University of Alabama, Birmingham; Keith E. Muller, University of North Carolina, Chapel Hill; Matthew J. Gurka, University of North Carolina, Chapel Hill
     11:50 AM   Statistical Methods for Pilot Bioequivalence Trials — Guohua Pan, Johnson & Johnson Pharmaceutical R&D, LLC; Yibin Wang, Novartis Pharmaceuticals
     12:05 PM   Optimal Three-stage Study Design for Single-arm Phase II Clinical Trials — Muhammad Jalaluddin, Pfizer Inc.; Enayet Talukder, Pfizer Inc.
 

JSM 2004 For information, contact jsm@amstat.org or phone (888) 231-3473. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2004